Clinical Trial Update: Assessing the Efficacy and Safety of ctDNA-driven Selection for Anti-EGFR Retreatment in a Real World Metastatic Colorectal Cancer Patients Cohort (the REalCHALLENGE Study)

View source ↗

Summary

A clinical trial investigating ctDNA-guided selection for retreatment with anti-EGFR therapy in real-world patients with metastatic colorectal cancer; currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Panitumumab (panitumumab)

Snippet

Sponsor: Niguarda Hospital | Conditions: Metastatic Colorectal Cancer (CRC) | Status: RECRUITING